Samir Rashmikant Patel - Dec 26, 2024 Form 4 Insider Report for Akari Therapeutics Plc (AKTX)

Role: Director
Signature: /s/ Torsten Hombeck, as Attorney-in-Fact
Stock symbol: AKTX
Transactions as of: Dec 26, 2024
Transactions value $: $1,800
Form type: 4
Date filed: 12/30/2024, 04:30 PM
Previous filing: Dec 27, 2024
Next filing: Jan 7, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AKTX	Ordinary Shares, par value $0.0001 per share	Award	$1.6K	+3.2M	+0.06%	$0.00	5.25B	Dec 26, 2024	PranaBio Investments LLC	F1, F2
transaction	AKTX	Ordinary Shares, par value $0.0001 per share	Award	$200	+400K	+0.01%	$0.00	5.25B	Dec 27, 2024	PranaBio Investments LLC	F1, F2, F3
holding	AKTX	Ordinary Shares, par value $0.0001 per share						91.4M	Dec 26, 2024	Direct

Showing 1 to 3 of 3 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares.
F2	On December 26, 2024, the Reporting Person acquired 3,200,000 Ordinary Shares at a purchase price of $0.0005 per Ordinary Share.
F3	On December 27, 2024 the Reporting Person acquired 400,000 Ordinary Shares at a purchase price of $0.0005 per Ordinary Share.